Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
PetMed Express, Inc. is a U.S.-based online pet pharmacy that operates primarily under the 1-800-PetMeds brand. The company provides prescription and non-prescription medications, health products, and supplies for companion animals, serving the pet healthcare and e-commerce retail industries. Its core offering centers on the convenient home delivery of pet medications, supported by licensed pharmacy operations and veterinarian authorization processes.
The company generates substantially all revenue through direct-to-consumer sales via its e-commerce platform, serving pet owners across the United States. PetMed Express is positioned as a pure-play online pet pharmacy, with brand recognition tied closely to its toll-free phone number and digital presence. Founded in 1996, the company went public in 1999 and has historically focused on organic growth within the pet medication market rather than diversification into broader pet retail categories.
Business Operations
PetMed Express operates as a single-reportable segment focused on online pet pharmacy services. Revenue is primarily derived from sales of prescription medications for chronic and acute conditions, alongside over-the-counter products such as flea and tick treatments, supplements, and wellness items. The company fulfills orders through centralized pharmacy and distribution facilities, leveraging proprietary e-commerce systems and customer service infrastructure.
Operations are almost entirely domestic, with sales concentrated in the United States. The company does not operate physical retail stores and does not report material international operations. PetMed Express conducts business through PetMed Express, Inc., doing business as 1-800-PetMeds, and does not disclose material joint ventures or equity-method investments in other companies.
Strategic Position & Investments
Strategically, PetMed Express has emphasized customer retention, cost control, and operational efficiency amid increasing competition from large pet retailers and e-commerce platforms. Growth initiatives in recent years have focused on marketing optimization, private-label product offerings, and improving digital customer experience rather than geographic expansion.
The company has historically maintained a conservative capital allocation strategy, with limited acquisition activity and a focus on returning capital to shareholders through dividends and share repurchases when cash flows allow. There is no publicly disclosed portfolio of subsidiaries or material investments in emerging technologies; available public filings indicate reliance on internally developed systems and established supplier relationships. Data inconclusive based on available public sources regarding any material future acquisitions or technology platform investments.
Geographic Footprint
PetMed Express is headquartered in Delray Beach, Florida, and its operational footprint is concentrated within the United States. Distribution and pharmacy operations are managed domestically to comply with U.S. veterinary pharmacy regulations, and customer fulfillment is targeted toward nationwide coverage.
The company does not report active operations, investments, or revenue generation outside North America. Its market presence is therefore limited to the U.S. pet healthcare market, with no disclosed international subsidiaries or cross-border strategic partnerships.
Leadership & Governance
PetMed Express is led by an executive team with experience in retail, e-commerce, and regulated consumer products. Leadership has emphasized operational discipline, regulatory compliance, and brand trust as core elements of its governance and strategic vision, particularly in a competitive and margin-sensitive industry.
Key executives disclosed in recent public filings include:
- Sandra E. Johnson – President and Chief Executive Officer
- Bruce S. Rosenbloom – Chief Financial Officer and Treasurer
Additional executive roles and long-term succession planning details are not consistently detailed across public sources; data inconclusive based on available public sources regarding other named executive officers beyond those listed above.